The Europe Shoulder Arthroplasty Market would witness market growth of 7.9% CAGR during the forecast period (2018 – 2024).
Shoulder arthroplasty or shoulder replacement is a surgical procedure used in the replacement of damaged ball and socket joint which is located in the shoulder. The surgical procedure is conducted using prosthesis, and it usually consists of polythene and metal components. Shoulder arthroplasty is a preferred modality and it is used in the treatment of osteoarthritis, rheumatoid arthritis, and osteonecrosis, as the procedures used have yielded great and reproducible results. In Europe, the growing obese population has driven the growth of the procedures segment. Nevertheless, the effort to cut healthcare costs in the region, and as a result, cut reimbursements for procedures will lead to the choice of alternative surgeries such as arthroscopic debridement and minimally invasive surgeries.
Based on Device, the market is segmented into Shoulder Arthroplasty Resurfacing Implants, Shoulder Arthroplasty Trauma Devices, and Shoulder Arthroplasty Platform Systems. Based on Procedure, the market is segmented into Partial Shoulder Arthroplasty, Total Shoulder Arthroplasty, and Revision Shoulder Arthroplasty. Based on Indication, the market is segmented into Fracture/Dislocation, Arthritis, Rotator Cuff Tear Arthropathy, Hill Sachs Defect, and Other Indication. Based on End User, the market is segmented into Hospitals & Clinics, and Outpatient Surgical Centers. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Wright Medical Group, Inc. /Tornier Inc., Integra Lifesciences Corporation, Zimmer Biomet, Johnson & Johnson, Smith & Nephew Plc., Arthrex, Inc., Conmed Corporation, Djo Global, Stryker Corporation, and Exactech, Inc.